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Abstract
Background: The JAMAR (Juvenile Arthritis Multidimensional Assessment Report) has been developed to evaluate the
perception of the patient and his parents on different items: well-being, pain, functional status, quality of life, disease
activity, disease course, side effects of medication, therapeutic compliance and satisfaction with illness outcome.
Our aim was to compare disease’s perception by JIA patients and their parents.
Methods: We included into the study 100 consecutive patients over 7 years of age. We asked both parent and child to
complete the JAMAR questionnaire. For each patient we recorded demographic and disease related data. We
examined the level of disagreement between children and parents for the quantitative items of the JAMAR: VAS Pain,
VAS Disease Activity, VAS Well Being, Juvenile Arthritis Functional Score, HRQoL. Then we looked for a relation between
discordance-rate and demographic and clinical variables.
Results: Children and parents’ median scores for all five items were similar. Individual dyads agreement was low, with a
large amount of pairs (80) discordant for at least one item.
We found higher MD VAS and JADAS in more discordant dyads, suggesting that when the disease is more active
discordance between child and parent increase.
Conclusion: The JAMAR questionnaire is an important tool that helps clinicians to detect divergent child and parent’s
disease perceptions. It is essential that both patients and parents fill the JAMAR questionnaire for a complete clinical
and psychosocial evaluation.
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Background
In recent years there has been an increasing interest in
parent/patient-centred reported outcomes in juvenile
idiopathic arthritis (JIA)[1–3]. These are important mea-
sures in patient assessment because they reflect the par-
ents and children’s perception of the disease course and
the effectiveness of medical interventions, and may con-
tribute significantly to medical decisions and to improv-
ing patient care.
The Juvenile Arthritis Multidimensional Assessment
Report (JAMAR) evaluates patient and parents’ disease
perception. JAMAR is proposed for use as only proxy-
report for patients younger than 7 years and as both self
and proxy report for patients aged 7–18 years [4].
The literature shows conflicting results on disagreement
between children with JIA and their parents in rating dis-
ability, pain, well-being and Health Related Quality of Life
(HRQoL) [5–8].
In clinical practice, relying only on parent-reports
gives us only partial information on the disease. It is
therefore of great importance to encourage children’s
ability to self-report verbally and in writing within paedi-
atric care [9]. The parents’ perception of their child’s
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disease and their estimation of its impact on daily life af-
fects health care utilization, so it is pivotal to increase
the knowledge about the relationship between parent
and child reporting. Parental perception can also influ-
ence the adolescent use of health care services and par-
ents are expected gradually to relinquish their care
giving responsibilities to their child. A different percep-
tion of the disease may also reflect family suffering, and
a lack of communication between the patient and his/
her parents. Therefore gaining more insight into child-
parent disagreement is important in patient care.
The aim of this study was to examine the level of dis-
agreement between children and parents for the quantita-
tive items of the JAMAR: VAS Pain (VAS P), VAS Disease
Activity (VAS DA), VAS Well Being (VAS WB), Juvenile
Arthritis Functional Score (JAFS), HRQoL. A further aim
was to identify factors associated to discordance.
Methods
Each consecutive JIA patient over 7 or 8 years of age
(depending on the child’s capacity to fill in the ques-
tionnaire on his/her own) seen at the paediatric
rheumatology units of Lausanne, Geneva, Neuchâtel
and Sion from May 2012 to June 2013 was included
into the study. We asked both the accompanying par-
ent and the child to independently complete a French
parent or child-version of the JAMAR. As some
patients came to our clinic more than once during the
study period, we considered only the first filled in
questionnaire.
For each patient we recorded demographic and disease
related data (International League Against Rheumatism
(ILAR) category, disease activity, number of active joints,
erythrocyte sedimentation rate (ESR), physician centred
measures) and calculated the Juvenile Arthritis Disease
Activity Score (JADAS-71) [10]. The JADAS combines
two physician-centred measures (physician global assess-
ment and active joint count), one parent/patient-centred
measure (parent/patient global assessment), and ESR. We
calculated the median score for the VAS P, VAS DA, VAS
WB, JAFS, HRQoL for children’s and parents’ groups.
We calculated the difference between child and parent
scores. We defined as discordant the pairs that had a
difference greater or equal to one for the VAS [5] and a
discordance in at least one answer for the JAFS and
HRQoL, leading to a difference of one or more in these
scores. We divided our population in six groups de-
pending on the number of discordant items: in group A
pairs were concordant for all items, in group B pairs
were discordant for one item, in group C for two items,
in group D for three items, in group E for four items,
and in group F for all items.
We compared demographic (age at disease’s onset, age
at visit, disease duration) and clinical variables (number
of active joints, physician evaluation of disease activity
(MD VAS), JADAS) between these six groups.
The Ethics Committee approved this study and we ob-
tained written informed consent from parents and patients.
Statistical analysis
We calculated children and parents’ median scores for
the five items.
Comparisons among the six groups for each vari-
able were performed using one-way ANOVA and
Tukey’s post hoc test. Statistical significance was set
at p < 0.05.
Results
A total of 100 child/parent pairs were included in the
study. Median age at visit was 13.3 years, median age
at disease onset was 7.9 years, median disease duration
was 4.7 years. There was a predominance of females
(72 females, 28 males) with a sex ratio of 2.6. Statistical
analysis of demographic variables showed no signifi-
cant differences between groups for age at visit/at diag-
nosis, duration of disease and number of active joints
(Additional file 1 Figure S1). Median number of actives
joints was 0 (range 0–11), median MD Global VAS was 1
(range 0–8) and median JADAS was 4 (range 0–18). All the
subtypes of JIA were represented with predominance for
oligoarticular (39 %) and enthesitis related JIA (36 %).
First, we analysed discrepancy between children and
parents’ median scores of all five items (VAS P, VAS DA,
VAS WB, JAFS, HRQoL): the differences between them
were not statistically significant.
Then we looked individually at each patient-parent
dyads. There were differences between child and parent’s
scores for at least one item in 80 pairs (80 %). For the five
items the differences were both in favour of children and
parents depending of the duo. There was an increase in
age at disease onset, age at visit, disease duration, number
of active joints, MD VAS and JADAS with the increasing
number of discordant items (Additional file 2 Table S1).
Analysis of MD VAS and JADAS showed significant
differences between groups (Fig. 1), but no differences
were found for the number of active joints (Additional
file 1 Figure S1). Post hoc analysis showed that MD
VAS was significantly higher in group E than in
group A (Additional file 3 Table S2); JADAS was sig-
nificantly higher in groups D, E and F than in group
A and in group E than in groups A and B (Additional
file 4 Table S3).
Discussion
We found substantial agreement between children’s
and parents medians scores in all evaluated items, as
already described [4]. However, individual dyads duo
agreement was low, with a large amount of pairs (80)
Vanoni et al. Pediatric Rheumatology  (2016) 14:2 Page 2 of 4
discordant for at least one item. Discordance in such
areas as functional ability, pain and overall well-being sug-
gests that parents and children may have a different percep-
tion of the disease.
Our results show an increased number of items with
disagreement between parents and children when the
disease is more active. In this case, child’s symptoms and
disease perception are more likely to be under/overesti-
mated by parents [5, 8], without a clear direction in the
difference as showed by our findings. In a previous report
on JIA focusing on proxy and adolescents’ agreement, Lal
et al. showed that their evaluations of pain and well-being
were more likely to disagree in those with severe disease.
They also observed that higher levels of agreement were
most representative of a high level of well being. They did
not find an explanation for this phenomenon [5].
Conversely, in an earlier report focusing on agreement
for pain, general well-being, functional disability, and
HRQOL in JIA patients, Shaw et al. found maximum
discordance in those with only moderate disease activity
[7]. April et al. explained their finding of higher levels of
agreement on pain for JIA patients with more severe dis-
ease, arguing that children with more severe disease
tended to have more pain and might have expressed this
to their parents [11].
Also, parents might give more attention to those who
have a more severe disease.
Our results show that a longer disease and the age of
the patient do not affect the discordance between children
and their parents, as also stated by Shaw et al. [7].
The divergence between proxy and children’s reports
does not imply that only the child’s perception reflects
reality. Opposing views may reflect their differing per-
spectives and are equally valid [12]. Parents may vary in
their perception of child health concerns, and therefore
health professionals should consider both children’s and
parents’ perspectives. The physician has to consider this
different perception and understand how it will impact
on JIA management and outcome. The integration of
these elements in patients care, could improve reliability
of patients-parents reports on disease activity, the adher-
ence to treatment and at the end disease management.
This study, looking not only on the global sample but
comparing patient/parent dyads duo, extends the per-
spective of JAMAR questionnaire’s use in the clinical
setting as compared to a previous publication [4].
Our study has some limitations. We used a convenience
sample that had a relatively low level of disease activity,
which is representative of our current clinical practice.
Children and their parents were not physically separated
when completing the questionnaires, which may have
biased some responses.
Our study is cross-sectional and causality cannot be
established. Longitudinal follow-up studies would allow
a better understanding of the effective disease’s impact
on health and quality of life and the impact of discord-
ance on disease’s outcome.
Conclusions
JAMAR is an important tool to explore different dis-
ease’s dimensions, and to give clinicians a large amount
of information on divergent child and parent’s disease
perceptions. The differences between patient’s and par-
ent’s reports emphasize the importance for professionals
to obtain precise information from both parents and
children to improve disease management. It is essential
that both patients and parents fill the JAMAR question-
naire for a complete clinical and psychosocial evaluation.
Additional files
Additional file 1: Figure S1. a) age at visit, b) age at disease onset, c)
disease duration and d) n° of actives joints in the six groups with results
of ANOVA test between groups. (PDF 152 kb)
Additional file 2: Table S1. Groups demographic and clinical variables.
Legend: Values are expressed as means. (PDF 24 kb)
Fig. 1 a MDVAS and b JADAS-71 in the six groups with results of
ANOVA test between groups
Vanoni et al. Pediatric Rheumatology  (2016) 14:2 Page 3 of 4
Additional file 3: Table S2. Tuckey post-hoc analysis between groups
for MD VAS. Legend: statistically significant differences between groups
in red. (PDF 50 kb)
Additional file 4: Table S3. Tuckey post-hoc analysis between groups
for JADAS. Legend: statistically significant differences between groups in
red. (PDF 55 kb)
Competing interests
None of the authors have any financial or any non-financial competing interests
(political, personal, religious, ideological, academic, intellectual, commercial or
any other) to declare in relation to this manuscript.
Authors’ contributions
FV designed the study, distributed the JAMAR questionnaire and collected
the responses, analyzed the data, and drafted the manuscript. JCS
participated in the design of the study, performed the statistical analyses and
helped to draft the manuscript. AVS and BF distributed the JAMAR
questionnaire and collected the responses. MH conceived the study,
participated in the design of the study, and helped to draft the manuscript.
All authors read and approved the final manuscript.
Acknowledgements
The authors would like to thank: Andrea Serino (Foundation Bertarelli Chair
in Cognitive Neuroprosthetics, EPFL, Lausanne) for statistical analysis; the
attending physicians of the Unité Romande d’Immuno- Rhumatologie
Pédiatrique for their help in collecting the JAMAR questionnaire.
Author details
1Unité Romande d’Immuno-Rhumatologie Pédiatrique (URIRP), Département
Médico - Chirurgical de Pédiatrie (DMCP), Centre Hospitalier Universitaire
Vaudois CHUV, University of Lausanne, Rue du Bugnon 46, 1011 Lausanne,
University of Geneva, Geneva, Switzerland. 2Groupe de recherche sur la santé
des adolescents (GRSA), Institut universitaire de médecine sociale et
préventive (IUMSP), Bâtiment Biopôle 2, Rte de la Corniche 10, 1010
Lausanne, Switzerland. 3Ligue genevoise contre le rhumatisme, Rue Merle
d’Aubigné 22, 1207 Genève, Switzerland.
Received: 21 July 2015 Accepted: 29 December 2015
References
1. Cuneo KM, Schiaffino KM. Adolescent self-perceptions of adjustment to
childhood arthritis: the influence of disease activity, family resources, and
parent adjustment. J Adolesc Heal. 2002;31:363–71.
2. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in
children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37(12):1761–9.
3. Cohen LL, Vowles KE, Eccleston C. Adolescent chronic pain-related
functioning: concordance and discordance of mother-proxy and self-report
ratings. Eur J pain London Engl. 2010;14:882–6.
4. Filocamo G, Consolaro A, Schiappapietra B, Dalprà S, Lattanzi B, Magni-Manzoni S,
et al. A new approach to clinical care of juvenile idiopathic arthritis: the juvenile
arthritis multidimensional assessment report. J Rheumatol. 2011;38(5):938–53.
5. Lal SD, McDonagh J, Baildam E, Wedderburn LR, Gardner-Medwin J, Foster
HE, et al. Agreement between proxy and adolescent assessment of
disability, pain, and well-being in juvenile idiopathic arthritis. J Pediatr. 2011;
158(2):307–12.
6. Sattoe JNT, Van Staa A, Moll HA. The proxy problem anatomized: child-
parent disagreement in health related quality of life reports of chronically ill
adolescents. Heal Qual Life Outcomes. 2012;10:10.
7. Shaw KL, Southwood TR, McDonagh JE. Growing up and moving on in
rheumatology: parents as proxies of adolescents with juvenile idiopathic
arthritis. Arthritis Rheum. 2006;55:189–98.
8. Garcia-Munitis P, Bandeira M, Pistorio A, Magni-Manzoni S, Ruperto N,
Schivo A, et al. Level of agreement between children, parents, and
physicians in rating pain intensity in juvenile idiopathic arthritis. Arthritis
Rheum. 2006;55:177–83.
9. Lundberg V, Lindh V, Eriksson C, Petersen S, Eurenius E. “Health-related
quality of life in girls and boys with juvenile idiopathic arthritis: self- and
parental reports in a cross-sectional study.,”. Pediatr Rheumatol Online J.
2012;10:33.
10. Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G,
et al. Development and validation of a composite disease activity score for
juvenile idiopathic arthritis. Arthritis Rheum. 2009;61(5):658–66.
11. April KT, Feldman DE, Platt RW, Duffy CM. Comparison between children
with juvenile idiopathic arthritis (JIA) and their parents concerning
perceived quality of life. Qual Life Res. 2006;15(4):655–61.
12. Achenbach TM, McConaughy SH, Howell CT. Child/adolescent behavioral
and emotional problems: implications of cross-informant correlations for
situational specificity. Psychol Bull. 1987;101:213–32.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Vanoni et al. Pediatric Rheumatology  (2016) 14:2 Page 4 of 4
